Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Other Operating Expenses (2023 - 2025)

Bioventus' Other Operating Expenses history spans 3 years, with the latest figure at $1000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $1000.0; the TTM value through Dec 2025 reached -$81000.0, up 72.26%, while the annual FY2025 figure was -$81000.0, 72.26% up from the prior year.
  • Other Operating Expenses reached $1000.0 in Q3 2025 per BVS's latest filing, up from -$1000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1000.0 in Q3 2025 to a low of -$1.4 million in Q3 2023.
  • Average Other Operating Expenses over 3 years is -$564285.7, with a median of -$292000.0 recorded in 2024.
  • The largest YoY upside for Other Operating Expenses was 75.59% in 2024 against a maximum downside of 75.59% in 2024.
  • A 3-year view of Other Operating Expenses shows it stood at -$1.2 million in 2023, then surged by 75.59% to -$292000.0 in 2024, then soared by 100.34% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Other Operating Expenses are $1000.0 (Q3 2025), -$1000.0 (Q2 2025), and -$81000.0 (Q1 2025).